Diseases
Companies
Products
Productz
Mechanisms of Action
Sites
Acute Myelogenous Leukemia
>>
Merck (MSD)
>>
Phase 2
Welcome,
Profile
Billing
Logout
All trials
Active industry trials
Active owner-sponsored trials
Active trials
Export
Download options
Which format:
PDF
Excel Chart
TSV
Phase
N/A
1
2
3
4
Trials
0
2
4
6
8
10
12
14
16
18
20
Keytruda
(pembrolizumab) / Merck (MSD)
Januvia
(sitagliptin) / Merck (MSD)
adavosertib
(AZD1775) / AstraZeneca
birabresib
(OTX015) / Merck (MSD)
bomedemstat
(MK-3543) / Merck (MSD)
MK-2206
/ Merck (MSD)
MK-8776
/ Merck (MSD)
dinaciclib
(MK-7965) / Merck (MSD)
Koselugo
(selumetinib) / Merck (MSD), AstraZeneca
